Results 291 to 300 of about 1,680,486 (323)

A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritis

open access: yesArthritis &Rheumatology, Accepted Article.
Background Individuals with serum elevations of anti‐cyclic citrullinated peptide (anti‐CCP) antibodies are at increased risk for future rheumatoid arthritis (RA). No pharmacologic interventions have been approved for the prevention of RA in such ‘at‐risk’ individuals. However, hydroxychloroquine (HCQ) is used without supporting clinical trial evidence.
Kevin D. Deane   +33 more
wiley   +1 more source

Viral infections in celiac disease: what should be considered for better management. [PDF]

open access: yesClin Exp Med
Asri N   +5 more
europepmc   +1 more source

ROS‐induced modifications of fibrin clots connect immune responses to atherothrombosis in systemic lupus erythematosus

open access: yesArthritis &Rheumatology, Accepted Article.
Objective Cardiovascular events are major determinants of morbidity and mortality in systemic lupus erythematosus (SLE), particularly in patients with renal involvement. While oxidative stress has been implicated in driving vascular and renal damage in SLE, the specific mechanisms remain unclear.
Matteo Becatti   +13 more
wiley   +1 more source

Challenges of concurrent HIV infection in the course and management of Crohn's disease. [PDF]

open access: yesJ Med Life
Mattar L   +8 more
europepmc   +1 more source

IgA Antibodies to Bovine Serum Albumin in Adult Patients with Celiac Disease. [PDF]

open access: yesInt J Mol Sci
Savvateeva E   +13 more
europepmc   +1 more source

Diagnostic Challenges in Enteropathies: A Histopathological Review. [PDF]

open access: yesDiagnostics (Basel)
Enache I   +5 more
europepmc   +1 more source

Heterologous antilymphocyte glubulin, histoincompatiblity matching, and human renal homotransplantation. [PDF]

open access: yes, 1968
Brettschneider, L   +5 more
core  

Home - About - Disclaimer - Privacy